Insider trading for US stocks based on disclosures made made on Jun 26, 2026

Monitor US insider transactions and discover insider buying and selling of stocks on Jun 26, 2026.

The latest disclosure under SEC insider trading regulations was reported by Hyliion Holdings Corporation - Ordinary Shares - Class A., where the revocation of 2,500,000 Common Stock of common stock was executed . This transaction was reported to the Securities and Exchange Commission on June 26, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Hyliion Holdings Corporation
Thomas Healy Director, Chief Executive Officer, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 26 Jun 2026 2,500,000 32,812,262 - 0 Common Stock
EchoStar Corp (Class A)
Charles W. Ergen Director, CHAIRMAN, PRES and CEO, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 26 Jun 2026 2,316,533 2,388,447 - - Class B Common Stock
EchoStar Corp (Class A)
Charles W. Ergen Director, CHAIRMAN, PRES and CEO, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 26 Jun 2026 2,316,533 14,483,467 - - Class B Common Stock
Navan Inc Ordinary Shares
Oren Zeev Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 Jun 2026 1,576,676 12,613,415 - 0 Class A Common Stock
Navan Inc Ordinary Shares
Oren Zeev Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 Jun 2026 1,576,676 14,190,091 - 0 Class A Common Stock
Navan Inc Ordinary Shares
Oren Zeev Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 Jun 2026 1,082,303 9,740,729 - 0 Class A Common Stock
Clear Secure Inc (Class A)
Caryn Seidman Becker Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 801,943 1,040,308 - 0 Class A Common Stock
Clear Secure Inc (Class A)
Caryn Seidman Becker Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 801,943 1,603,888 - - Performance Restricted Stock Units
Schrodinger Inc
Richard A. Friesner Director Gift of securities by or to the insider at price $ 0.00 per share. 26 Jun 2026 679,373 679,373 (1%) 1% 0 Common Stock
Schrodinger Inc
Richard A. Friesner Director Gift of securities by or to the insider at price $ 0.00 per share. 26 Jun 2026 679,373 0 (0%) 1% 0 Common Stock
Roivant Sciences Ltd
Keith Manchester Director Sale of securities on an exchange or to another person at price $ 34.59 per share. 26 Jun 2026 600,000 13,701,546 - 34.6 20,754,000 Common Shares
Roivant Sciences Ltd
Daniel Gold Director Sale of securities on an exchange or to another person at price $ 34.59 per share. 26 Jun 2026 600,000 13,701,546 - 34.6 20,754,000 Common Shares
Navan Inc Ordinary Shares
Oren Zeev Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 Jun 2026 567,965 1,135,930 - 0 Class A Common Stock
Navan Inc Ordinary Shares
Oren Zeev Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 Jun 2026 567,965 567,965 - 0 Class A Common Stock
Jupiter Neurosciences Inc
Tomas J. Philipson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 536,428 536,428 - - Stock Option (right to buy)
Navan Inc Ordinary Shares
Oren Zeev Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 Jun 2026 452,949 4,076,544 - 0 Class A Common Stock
Navan Inc Ordinary Shares
Oren Zeev Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 Jun 2026 452,949 3,623,595 - 0 Class A Common Stock
LifeStance Health Grp Inc
Robert Bessler Director Sale of securities on an exchange or to another person at price $ 10.13 per share. 26 Jun 2026 447,169 656,560 - 10.1 4,529,822 Common Stock
LifeStance Health Grp Inc
Robert Bessler Director Sale of securities on an exchange or to another person at price $ 10.13 per share. 26 Jun 2026 447,168 539,763 - 10.1 4,529,812 Common Stock
Clear Secure Inc (Class A)
Caryn Seidman Becker Director, Chief Executive Officer, Ten Percent Owner Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.17 per share. 26 Jun 2026 443,475 596,833 - 55.2 24,466,516 Class A Common Stock
Roivant Sciences Ltd
Keith Manchester Director Sale of securities on an exchange or to another person at price $ 34.07 per share. 26 Jun 2026 325,000 14,501,546 - 34.1 11,072,750 Common Shares
Roivant Sciences Ltd
Daniel Gold Director Sale of securities on an exchange or to another person at price $ 34.07 per share. 26 Jun 2026 325,000 14,501,546 - 34.1 11,072,750 Common Shares
Roivant Sciences Ltd
Keith Manchester Director Sale of securities on an exchange or to another person at price $ 33.92 per share. 26 Jun 2026 300,783 14,826,546 - 33.9 10,202,559 Common Shares
Roivant Sciences Ltd
Daniel Gold Director Sale of securities on an exchange or to another person at price $ 33.92 per share. 26 Jun 2026 300,783 14,826,546 - 33.9 10,202,559 Common Shares
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 108.14 per share. 26 Jun 2026 231,007 2,603,048 - 108.1 24,981,097 Common Stock
Roivant Sciences Ltd
Keith Manchester Director Sale of securities on an exchange or to another person at price $ 35.45 per share. 26 Jun 2026 200,000 1,748,403 - 35.5 7,090,000 Common Shares
Roivant Sciences Ltd
Keith Manchester Director Sale of securities on an exchange or to another person at price $ 34.44 per share. 26 Jun 2026 200,000 14,301,546 - 34.4 6,888,000 Common Shares
Roivant Sciences Ltd
Daniel Gold Director Sale of securities on an exchange or to another person at price $ 34.44 per share. 26 Jun 2026 200,000 14,301,546 - 34.4 6,888,000 Common Shares
Dyne Therapeutics Inc
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 21.28 per share. 26 Jun 2026 162,954 4,579,456 - 21.3 3,467,661 Common Stock
Inhibikase Therapeutics Inc
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 155,000 155,000 - - Stock Option (Right to Buy)
Inhibikase Therapeutics Inc
Roberto Bellini Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 155,000 155,000 - - Stock Option (Right to Buy)
Inhibikase Therapeutics Inc
Amit D. Munshi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 155,000 155,000 - - Stock Option (Right to Buy)
Inhibikase Therapeutics Inc
Vincent E. Aurentz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 155,000 155,000 - - Stock Option (Right to Buy)
Inhibikase Therapeutics Inc
Arvind Kush Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 155,000 155,000 - - Stock Option (Right to Buy)
Inhibikase Therapeutics Inc
David Canner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 155,000 155,000 - - Stock Option (Right to Buy)
Adaptive biotech Corp
Sharon Benzeno Chief Commercial Ofc Imm Med Sale of securities on an exchange or to another person at price $ 21.14 per share. 26 Jun 2026 154,768 221,278 (0%) 0% 21.1 3,271,796 Common Stock
Guardant Health Inc
AmirAli Talasaz Director, Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 143,028 28,997 - - Stock Option (Right to Buy)
Guardant Health Inc
AmirAli Talasaz Director, Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. 26 Jun 2026 143,028 2,024,364 (2%) 0% 4.2 597,857 Common Stock
Trulieve Cannabis Corp
Kim A. Rivers Director, Chairman and CEO, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.76 per share. 26 Jun 2026 136,811 1,476,913 - 8.8 1,197,917 Subordinate Voting Shares
Eos Energy Enterprises Inc (Class A)
Joe Mastrangelo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 130,570 1,701,050 - 0 Common Stock
Eos Energy Enterprises Inc (Class A)
Joe Mastrangelo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 130,570 261,140 - - Restricted Stock Units
Guardant Health Inc
AmirAli Talasaz Director, Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 111,804 172,025 - - Stock Option (Right to Buy)
Guardant Health Inc
AmirAli Talasaz Director, Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. 26 Jun 2026 111,804 1,998,308 (2%) 0% 4.2 467,341 Common Stock
Mineralys Therapeutics Inc
Eric Warren Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 104,124 252,876 - - Stock Option
Mineralys Therapeutics Inc
Eric Warren Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 25.90 per share. 26 Jun 2026 104,124 38,400 - 25.9 2,696,322 Common Stock
Mineralys Therapeutics Inc
Eric Warren Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.24 per share. 26 Jun 2026 104,124 142,524 - 13.2 1,378,602 Common Stock
Dyne Therapeutics Inc
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 21.14 per share. 26 Jun 2026 102,969 4,476,487 - 21.1 2,176,765 Common Stock
Personalis Inc
Christopher Hall Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 13.15 per share. 26 Jun 2026 100,000 235,986 (0%) 0% 13.2 1,315,000 Common Stock
Personalis Inc
Christopher Hall Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 100,000 200,000 - - Stock Option (right to buy)
Personalis Inc
Christopher Hall Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share. 26 Jun 2026 100,000 335,986 (1%) 0% 1.6 161,000 Common Stock
Affirm Holdings Inc (Class A)
Michael Linford Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.39 per share. 26 Jun 2026 100,000 217,984 - 5.4 539,000 Class A Common Stock
Affirm Holdings Inc (Class A)
Michael Linford Chief Operating Officer Sale of securities on an exchange or to another person at price $ 80.04 per share. 26 Jun 2026 100,000 117,984 - 80.0 8,004,000 Class A Common Stock
Affirm Holdings Inc (Class A)
Michael Linford Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 100,000 433,870 - - Stock Option (Right to Buy)
PaySign Inc
Joan M. Herman Director, EVP, Operations Sale of securities on an exchange or to another person at price $ 8.01 per share. 26 Jun 2026 100,000 707,009 (1%) 0% 8.0 801,140 Common Stock
Outset Medical Inc
Leslie L. Trigg Director, Chair and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 99,160 198,034 - 0 Common Stock
Airbnb
Nathan Blecharczyk Director, Chief Strategy Officer, Ten Percent Owner 26 Jun 2026 96,263 108,633 - - Class A Common Stock
Airbnb
Nathan Blecharczyk Director, Chief Strategy Officer, Ten Percent Owner 26 Jun 2026 96,263 45,770,277 - - Class B Common Stock
Privia Health Group Inc
M. Shawn Morris Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. 26 Jun 2026 88,110 164,761 - 2 176,220 Common Stock, par value $0.01 per share
Privia Health Group Inc
M. Shawn Morris Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 88,110 3,586,091 - - Stock Option (Right to Purchase)
Privia Health Group Inc
M. Shawn Morris Director Sale of securities on an exchange or to another person at price $ 25.33 per share. 26 Jun 2026 88,110 76,651 - 25.3 2,231,826 Common Stock, par value $0.01 per share
Dyne Therapeutics Inc
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 21.28 per share. 26 Jun 2026 81,903 1,396,475 - 21.3 1,742,896 Common Stock
Gaia Inc (Class A)
Ned Preston CFO Grant, award, or other acquisition of securities at price $ 2.08 per share. 26 Jun 2026 76,220 90,444 (0%) 0% 2.1 158,538 Class A Common Stock
Outset Medical Inc
Renee M. Gaeta Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 71,630 185,383 - 0 Common Stock
Guardant Health Inc
AmirAli Talasaz Director, Co-Chief Executive Officer Sale of securities on an exchange or to another person at price $ 151.47 per share. 26 Jun 2026 70,513 1,928,039 (2%) 0% 151.5 10,680,315 Common Stock
Fidelity National Fin Inc
Peter T. Sadowski EVP, Chief Legal Officer Sale of securities on an exchange or to another person at price $ 45.70 per share. 26 Jun 2026 69,196 5,702 (0%) 0% 45.7 3,162,375 Common Stock
Mammoth Energy Services Inc
Phillip Lancaster Director Other type of transaction at price $ 0.00 per share. 26 Jun 2026 68,152 159,445 (0%) 0% 0 Common Stock
Dyne Therapeutics Inc
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 21.28 per share. 26 Jun 2026 64,411 1,016,633 - 21.3 1,370,666 Common Stock
Guardant Health Inc
AmirAli Talasaz Director, Co-Chief Executive Officer Sale of securities on an exchange or to another person at price $ 150.49 per share. 26 Jun 2026 64,037 1,934,271 (2%) 0% 150.5 9,636,838 Common Stock
Privia Health Group Inc
M. Shawn Morris Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 63,212 3,522,879 - - Stock Option (Right to Purchase)
Privia Health Group Inc
M. Shawn Morris Director Sale of securities on an exchange or to another person at price $ 25.33 per share. 26 Jun 2026 63,212 76,651 - 25.3 1,601,160 Common Stock, par value $0.01 per share
Privia Health Group Inc
M. Shawn Morris Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. 26 Jun 2026 63,212 139,863 - 2 126,424 Common Stock, par value $0.01 per share
Eos Energy Enterprises Inc (Class A)
Joe Mastrangelo Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.09 per share. 26 Jun 2026 60,703 1,640,347 - 6.1 369,681 Common Stock
Outset Medical Inc
John L. Brottem General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 59,830 90,107 - 0 Common Stock
Liberty Latin America Ltd (Class A)
John M. Winter SVP, CLO AND SECRETARY Other type of transaction at price $ 0.00 per share. 26 Jun 2026 59,476 59,476 - 0 Series A Preference Shares
Lifeway Foods Inc
Edward P. Smolyansky Ten Percent Owner Sale of securities on an exchange or to another person at price $ 29.87 per share. 26 Jun 2026 55,794 902,642 (5%) 0% 29.9 1,666,567 Common Stock, no par value
Lifeway Foods Inc
Edward P. Smolyansky Ten Percent Owner Sale of securities on an exchange or to another person at price $ 28.64 per share. 26 Jun 2026 55,754 958,436 (6%) 0% 28.6 1,596,795 Common Stock, no par value
Guardant Health Inc
AmirAli Talasaz Director, Co-Chief Executive Officer Sale of securities on an exchange or to another person at price $ 151.16 per share. 26 Jun 2026 52,935 1,881,336 (1%) 0% 151.2 8,001,628 Common Stock
Dyne Therapeutics Inc
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 21.14 per share. 26 Jun 2026 51,756 1,344,719 - 21.1 1,094,122 Common Stock
Adaptive biotech Corp
Sharon Benzeno Chief Commercial Ofc Imm Med Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.12 per share. 26 Jun 2026 51,570 376,046 (0%) 0% 8.1 418,748 Common Stock
Adaptive biotech Corp
Sharon Benzeno Chief Commercial Ofc Imm Med Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 51,570 113,457 - - Stock Option (right to buy)
Personalis Inc
Aaron L. Tachibana CFO AND COO Sale of securities on an exchange or to another person at price $ 13.18 per share. 26 Jun 2026 51,251 198,833 (0%) 0% 13.2 675,488 Common Stock
ATAI Life Sciences N.V.
Gerd Kochendoerfer Chief Operating Officer Sale of securities on an exchange or to another person at price $ 5.00 per share. 26 Jun 2026 50,000 0 - 5 250,000 Common Stock
ATAI Life Sciences N.V.
Gerd Kochendoerfer Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 50,000 1,400,000 - - Stock Option
ATAI Life Sciences N.V.
Gerd Kochendoerfer Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.60 per share. 26 Jun 2026 50,000 50,000 - 1.6 80,000 Common Stock
Lifeway Foods Inc
Edward P. Smolyansky Ten Percent Owner Sale of securities on an exchange or to another person at price $ 29.56 per share. 26 Jun 2026 50,000 852,642 (5%) 0% 29.6 1,478,000 Common Stock, no par value
Galectin Therapeutics Inc
Khurram Jamil Chief Medical Officer Sale of securities on an exchange or to another person at price $ 5.04 per share. 26 Jun 2026 47,467 0 (0%) 0% 5.0 239,234 Common Stock
Galectin Therapeutics Inc
Khurram Jamil Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 47,467 0 - - Stock Option (right to buy)
Galectin Therapeutics Inc
Khurram Jamil Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 26 Jun 2026 47,467 47,467 (0%) 0% 2.5 118,668 Common Stock
Guardant Health Inc
AmirAli Talasaz Director, Co-Chief Executive Officer Sale of securities on an exchange or to another person at price $ 152.20 per share. 26 Jun 2026 46,663 1,881,376 (1%) 0% 152.2 7,102,319 Common Stock
SEI Investments Co.
Alfred P. West Chairman Emeritus Sale of securities on an exchange or to another person at price $ 87.21 per share. 26 Jun 2026 46,162 6,829,621 (4%) 0% 87.2 4,025,788 Common Stock
Archer Aviation Inc (Class A)
Oscar Munoz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 40,983 40,983 - - Restricted Stock Units
Archer Aviation Inc (Class A)
Fred M. Diaz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 40,983 40,983 - - Deferred Restricted Stock Units
Archer Aviation Inc (Class A)
Deborah B. Diaz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 40,983 40,983 - - Restricted Stock Units
Archer Aviation Inc (Class A)
Maria Pinelli Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 40,983 40,983 - - Restricted Stock Units
Dyne Therapeutics Inc
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 21.14 per share. 26 Jun 2026 40,702 975,931 - 21.1 860,440 Common Stock
Black Diamond Therapeutics Inc
Kapil Dhingra Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 40,000 40,000 - - Stock Option (Right to Buy)
Black Diamond Therapeutics Inc
Garry E. Menzel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 40,000 40,000 - - Stock Option (Right to Buy)
Black Diamond Therapeutics Inc
Ali Behbahani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 40,000 40,000 - - Stock Option (Right to Buy)
Black Diamond Therapeutics Inc
Samarth Kulkarni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 40,000 40,000 - - Stock Option (Right to Buy)
Black Diamond Therapeutics Inc
Prakash Raman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 40,000 40,000 - - Stock Option (Right to Buy)
Black Diamond Therapeutics Inc
Shannon Campbell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 40,000 40,000 - - Stock Option (Right to Buy)
Worthington Steel Inc
Geoffrey G. Gilmore Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 39,915 344,932 - 0 Common Shares
Oportun Fin Corp
Richard N. Tambor Director Gift of securities by or to the insider at price $ 0.00 per share. 26 Jun 2026 36,127 40,650 (0%) 0% - Common Stock
Oportun Fin Corp
Richard N. Tambor Director Gift of securities by or to the insider at price $ 0.00 per share. 26 Jun 2026 36,127 36,127 (0%) 0% - Common Stock
Oportun Fin Corp
Richard N. Tambor Director Gift of securities by or to the insider at price $ 0.00 per share. 26 Jun 2026 36,127 4,523 (0%) 0% - Common Stock
Oportun Fin Corp
Richard N. Tambor Director Gift of securities by or to the insider at price $ 0.00 per share. 26 Jun 2026 36,127 36,127 (0%) 0% - Common Stock
Immunovant Inc
Jay S. Stout Chief Technology Officer Sale of securities on an exchange or to another person at price $ 38.18 per share. 26 Jun 2026 33,277 218,408 (0%) 0% 38.2 1,270,516 Common Stock
Omada Health Inc
Steve Cook Chief Financial Officer Sale of securities on an exchange or to another person at price $ 19.89 per share. 26 Jun 2026 33,000 133,359 - 19.9 656,449 Common Stock
Omada Health Inc
Steve Cook Chief Financial Officer Sale of securities on an exchange or to another person at price $ 19.89 per share. 26 Jun 2026 33,000 187,209 - 19.9 656,449 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 109.79 per share. 26 Jun 2026 32,624 2,570,424 - 109.8 3,581,789 Common Stock
Petmed Express Inc
Douglas Krulik CAO and Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 32,500 102,500 (0%) 0% 0 Common Stock
Petmed Express Inc
Douglas Krulik CAO and Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 32,500 32,500 - - Performance Share Units
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 108.14 per share. 26 Jun 2026 32,402 493,358 - 108.1 3,503,952 Common Stock
Consumer Portfolio Service Inc
Charles E. Gonel Sr. Vice President Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.53 per share. 26 Jun 2026 30,000 54,847 (0%) 0% 3.5 105,900 Common Stock, no par value
Consumer Portfolio Service Inc
Charles E. Gonel Sr. Vice President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 30,000 0 - - Stock Option (right to buy)
Eos Energy Enterprises Inc (Class A)
Michael W Silberman Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 29,996 313,275 - 0 Common Stock
Eos Energy Enterprises Inc (Class A)
Michael W Silberman Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 29,996 59,991 - - Restricted Stock Units
Erasca Inc
Alexander W. Casdin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
Erasca Inc
Jean I. Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
Erasca Inc
Julie Hambleton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
Erasca Inc
Pratik S. Multani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
Erasca Inc
James A. Bristol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
Erasca Inc
Valerie Harding Start Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
Personalis Inc
Aaron L. Tachibana CFO AND COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.16 per share. 26 Jun 2026 28,832 227,665 (0%) 0% 9.2 264,101 Common Stock
Personalis Inc
Aaron L. Tachibana CFO AND COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 28,832 0 - - Stock Option (right to buy)
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 107.57 per share. 26 Jun 2026 28,296 2,834,055 - 107.6 3,043,801 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 114.94 per share. 26 Jun 2026 27,951 2,505,362 - 114.9 3,212,688 Common Stock
Village Farms Intl Inc
Michael A. DeGiglio Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.89 per share. 26 Jun 2026 26,400 9,682,175 (18%) 0% 1.9 49,896 Common Shares
Ionis Pharma Inc
Eugene Schneider EVP, Chf Clinical Develop Ofcr Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.89 per share. 26 Jun 2026 26,000 103,114 (0%) 0% 60.9 1,583,140 Common Stock
Ionis Pharma Inc
Eugene Schneider EVP, Chf Clinical Develop Ofcr Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 26,000 26,000 - - Non-Qualified Stock Option (right to buy)
Ionis Pharma Inc
Eugene Schneider EVP, Chf Clinical Develop Ofcr Sale of securities on an exchange or to another person at price $ 81.05 per share. 26 Jun 2026 26,000 77,114 (0%) 0% 81.0 2,107,196 Common Stock
Guardant Health Inc
AmirAli Talasaz Director, Co-Chief Executive Officer Sale of securities on an exchange or to another person at price $ 150.53 per share. 26 Jun 2026 25,812 1,998,552 (2%) 0% 150.5 3,885,434 Common Stock
Stubhub Holdings Inc
Nayaab Islam See Remarks Sale of securities on an exchange or to another person at price $ 12.05 per share. 26 Jun 2026 25,080 8,538,364 - 12.0 302,141 Class A Common Stock
Alignment Healthcare Inc
Joseph Konowiecki Director, EVP, Corporate Affairs Sale of securities on an exchange or to another person at price $ 23.00 per share. 26 Jun 2026 25,000 1,128,816 - 23 575,000 Common Stock
American Healthcare REIT Inc
Brian S. Peay Chief Financial Officer Sale of securities on an exchange or to another person at price $ 50.70 per share. 26 Jun 2026 25,000 152,700 - 50.7 1,267,403 Common Stock
Adaptive biotech Corp
Sharon Benzeno Chief Commercial Ofc Imm Med Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. 26 Jun 2026 24,944 299,532 (0%) 0% 8.5 211,026 Common Stock
Adaptive biotech Corp
Sharon Benzeno Chief Commercial Ofc Imm Med Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. 26 Jun 2026 24,944 324,476 (0%) 0% 4.0 99,527 Common Stock
Adaptive biotech Corp
Sharon Benzeno Chief Commercial Ofc Imm Med Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 24,944 37,416 - - Stock Option (right to buy)
Adaptive biotech Corp
Sharon Benzeno Chief Commercial Ofc Imm Med Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 24,944 87,303 - - Stock Option (right to buy)
IDT Corp (Class B)
Marcelo Fischer Chief Financial Officer Sale of securities on an exchange or to another person at price $ 56.98 per share. 26 Jun 2026 23,323 32,824 (0%) 0% 57.0 1,329,024 Class B Common Stock, $.01 par value per share
Eos Energy Enterprises Inc (Class A)
Michelle Buczkowski Chief Administration Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 22,938 70,711 - 0 Common Stock
Eos Energy Enterprises Inc (Class A)
Michelle Buczkowski Chief Administration Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 22,938 45,876 - - Restricted Stock Units
Canopy Growth Corp
David Lazzarato Director Sale of securities on an exchange or to another person at price $ 0.92 per share. 26 Jun 2026 22,674 211,859 (0%) 0% 0.9 20,944 Common Shares
Personalis Inc
Aaron L. Tachibana CFO AND COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 22,419 7,471 - - Stock Option (right to buy)
Personalis Inc
Aaron L. Tachibana CFO AND COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.32 per share. 26 Jun 2026 22,419 250,084 (0%) 0% 5.3 119,269 Common Stock
Galectin Therapeutics Inc
Harold H. Shlevin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 22,268 30,000 - - Stock Option (right to buy)
Galectin Therapeutics Inc
Harold H. Shlevin Director Sale of securities on an exchange or to another person at price $ 5.04 per share. 26 Jun 2026 22,268 6,500 (0%) 0% 5.0 112,231 Common Stock
Galectin Therapeutics Inc
Harold H. Shlevin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.23 per share. 26 Jun 2026 22,268 28,768 (0%) 0% 1.2 27,390 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 117.85 per share. 26 Jun 2026 22,046 2,464,314 - 117.8 2,598,121 Common Stock
Gaia Inc (Class A)
Ned Preston CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.08 per share. 26 Jun 2026 21,417 69,027 (0%) 0% 2.1 44,547 Class A Common Stock
Omada Health Inc
Steve Cook Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,427 20,834 - - Stock Option (Right to Buy)
Omada Health Inc
Steve Cook Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.01 per share. 26 Jun 2026 19,427 220,209 - 8.0 155,610 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 107.76 per share. 26 Jun 2026 19,419 2,412,158 - 107.8 2,092,591 Common Stock
Lithium Americas Corp
Philip Montgomery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,348 38,697 - - Restricted Share Units ("RSUs")
Lithium Americas Corp
Philip Montgomery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,348 19,348 - - Common Shares
Orion Engineered Carbons S.A.
Dan F. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,150 110,857 (0%) 0% 0 Common shares, no par value
Orion Engineered Carbons S.A.
Yi Hyon Paik Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,150 65,039 (0%) 0% 0 Common shares, no par value
Orion Engineered Carbons S.A.
Kerry A. Galvin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,150 84,753 (0%) 0% 0 Common shares, no par value
Orion Engineered Carbons S.A.
Paul E. Huck Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,150 103,357 (0%) 0% 0 Common shares, no par value
Orion Engineered Carbons S.A.
Didier Miraton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,150 73,357 (0%) 0% 0 Common shares, no par value
Orion Engineered Carbons S.A.
Mary A. Lindsey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,150 75,039 (0%) 0% 0 Common shares, no par value
Orion Engineered Carbons S.A.
Jacqueline Hoogerbrugge Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,150 32,085 (0%) 0% 0 Common shares, no par value
Archer Aviation Inc (Class A)
Oscar Munoz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,102 461,223 - 0 Class A Common Stock
Archer Aviation Inc (Class A)
Oscar Munoz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,102 0 - - Restricted Stock Units
Archer Aviation Inc (Class A)
Fred M. Diaz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,102 126,457 - 0 Class A Common Stock
Archer Aviation Inc (Class A)
Fred M. Diaz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,102 0 - - Restricted Stock Units
Archer Aviation Inc (Class A)
Deborah B. Diaz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,102 0 - - Restricted Stock Units
Archer Aviation Inc (Class A)
Deborah B. Diaz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,102 172,632 - 0 Class A Common Stock
Archer Aviation Inc (Class A)
Michael Spellacy Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,102 0 - - Restricted Stock Units
Archer Aviation Inc (Class A)
Michael Spellacy Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,102 73,746 - 0 Class A Common Stock
Archer Aviation Inc (Class A)
Maria Pinelli Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,102 0 - - Restricted Stock Units
Archer Aviation Inc (Class A)
Maria Pinelli Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 19,102 201,787 - 0 Class A Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 107.76 per share. 26 Jun 2026 19,093 2,412,747 - 107.8 2,057,462 Common Stock
Contineum Therapeutics Inc (Class A)
Troy A. Ignelzi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,000 19,000 - - Stock Option (right to buy)
Contineum Therapeutics Inc (Class A)
Sarah Boyce Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,000 19,000 - - Stock Option (right to buy)
Contineum Therapeutics Inc (Class A)
Olivia C. Ware Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,000 19,000 - - Stock Option (right to buy)
Contineum Therapeutics Inc (Class A)
Lori Lyons-Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,000 19,000 - - Stock Option (right to buy)
Contineum Therapeutics Inc (Class A)
Evert B. Schimmelpennink Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,000 19,000 - - Stock Option (right to buy)
Contineum Therapeutics Inc (Class A)
Diego Miralles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 19,000 19,000 - - Stock Option (right to buy)
Fulcrum Therapeutics Inc
Alan Ezekowitz Director Sale of securities on an exchange or to another person at price $ 3.65 per share. 26 Jun 2026 18,000 10,927 (0%) 0% 3.6 65,614 Common Stock
Omada Health Inc
Steve Cook Chief Financial Officer Sale of securities on an exchange or to another person at price $ 21.07 per share. 26 Jun 2026 17,950 115,409 - 21.1 378,167 Common Stock
Omada Health Inc
Steve Cook Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.28 per share. 26 Jun 2026 17,950 205,159 - 8.3 148,626 Common Stock
Omada Health Inc
Steve Cook Chief Financial Officer Sale of securities on an exchange or to another person at price $ 21.07 per share. 26 Jun 2026 17,950 187,209 - 21.1 378,167 Common Stock
Omada Health Inc
Steve Cook Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 17,950 301,809 - - Stock Option (Right to Buy)
Immunovant Inc
Christopher A. Van Tuyl Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 17,824 53,707 - - Stock Option (right to buy)
Immunovant Inc
Christopher A. Van Tuyl Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.20 per share. 26 Jun 2026 17,824 198,421 (0%) 0% 15.2 270,925 Common Stock
Cathay General Bancorp
Chang M. Liu Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 17,727 17,727 - - Restricted Stock Units
Eos Energy Enterprises Inc (Class A)
Sumeet Puri Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 17,645 181,935 - 0 Common Stock
Eos Energy Enterprises Inc (Class A)
Sumeet Puri Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 17,545 35,389 - - Restricted Stock Units
Privia Health Group Inc
David Mountcastle EVP & Chief Financial Officer Sale of securities on an exchange or to another person at price $ 25.18 per share. 26 Jun 2026 17,196 211,462 - 25.2 432,995 Common Stock, par value $0.01 per share
Privia Health Group Inc
David Mountcastle EVP & Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. 26 Jun 2026 17,196 228,658 - 2 34,392 Common Stock, par value $0.01 per share
Canopy Growth Corp
Theresa Yanofsky Director Sale of securities on an exchange or to another person at price $ 0.92 per share. 26 Jun 2026 15,054 146,415 (0%) 0% 0.9 13,905 Common Shares
Vericel Corp
Sean C. Flynn Chief Legal Officer Sale of securities on an exchange or to another person at price $ 45.64 per share. 26 Jun 2026 15,000 1,647 (0%) 0% 45.6 684,600 Common Stock
Vericel Corp
Sean C. Flynn Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 15,000 55,000 - - Stock Option (Right to Buy)
Vericel Corp
Sean C. Flynn Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.25 per share. 26 Jun 2026 15,000 16,647 (0%) 0% 16.3 243,750 Common Stock
Septerna Inc
Shalini Sharp Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 15,000 15,000 - - Stock Option (Right to Buy)
Septerna Inc
Alan Ezekowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 15,000 15,000 - - Stock Option (Right to Buy)
Septerna Inc
Bernard Coulie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 15,000 15,000 - - Stock Option (Right to Buy)
Septerna Inc
Jake Simson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 15,000 15,000 - - Stock Option (Right to Buy)
Septerna Inc
Abraham Bassan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 15,000 15,000 - - Stock Option (Right to Buy)
Eos Energy Enterprises Inc (Class A)
Michael W Silberman Chief Legal Officer Sale of securities on an exchange or to another person at price $ 5.87 per share. 26 Jun 2026 14,998 298,277 - 5.9 88,038 Common Stock
Immunovant Inc
Christopher A. Van Tuyl Chief Legal Officer Sale of securities on an exchange or to another person at price $ 38.19 per share. 26 Jun 2026 14,982 183,439 (0%) 0% 38.2 572,163 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 113.97 per share. 26 Jun 2026 14,913 2,533,313 - 114.0 1,699,635 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 106.63 per share. 26 Jun 2026 14,798 2,431,577 - 106.6 1,577,911 Common Stock
AIAI Holdings Corp Ordinary
Barbara Barton Weiszhaar SVP/CAO Sale of securities on an exchange or to another person at price $ 14.21 per share. 26 Jun 2026 14,781 161,339 - 14.2 210,038 Class A Common Stock
AIAI Holdings Corp Ordinary
Stephanie Liebman EVP/CFO Sale of securities on an exchange or to another person at price $ 14.21 per share. 26 Jun 2026 14,780 161,259 - 14.2 210,024 Class A Common Stock
Immunovant Inc
Melanie Gloria Chief Operating Officer Sale of securities on an exchange or to another person at price $ 38.18 per share. 26 Jun 2026 14,748 227,359 (0%) 0% 38.2 563,079 Common Stock
Worthington Steel Inc
John B. Blystone Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 14,665 241,029 - 0 Common Shares
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 106.63 per share. 26 Jun 2026 14,613 2,431,840 - 106.6 1,558,184 Common Stock
Intapp Inc
Michele Murgel Chief People & Places Officer Sale of securities on an exchange or to another person at price $ 25.02 per share. 26 Jun 2026 14,591 233,632 - 25.0 365,127 Common Stock
Lifeway Foods Inc
Edward P. Smolyansky Ten Percent Owner Sale of securities on an exchange or to another person at price $ 30.12 per share. 26 Jun 2026 14,542 1,168,791 (7%) 0% 30.1 438,005 Common Stock, no par value
Vicor Corp
Patrizio Vinciarelli Director, Chairman & CEO, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 326.93 per share. 26 Jun 2026 14,400 8,428,090 (29%) 0% 326.9 4,707,792 Common Stock
Wheeler Real Estate Investment Trust Inc
Joseph D. Stilwell Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Jun 2026 13,895 90,565 - - Series B Convertible Preferred Stock
La-Z-Boy Inc
Raphaell Z. Richmond VP, GC & Chief Compliance Off Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.41 per share. 26 Jun 2026 13,671 65,366 (0%) 0% 24.4 333,709 Common Shares
La-Z-Boy Inc
Raphaell Z. Richmond VP, GC & Chief Compliance Off Sale of securities on an exchange or to another person at price $ 39.83 per share. 26 Jun 2026 13,671 51,695 (0%) 0% 39.8 544,534 Common Shares
La-Z-Boy Inc
Raphaell Z. Richmond VP, GC & Chief Compliance Off Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 13,671 0 - - Employee Stock Options (right to buy)
Village Farms Intl Inc
Michael A. DeGiglio Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.87 per share. 26 Jun 2026 13,600 9,695,775 (18%) 0% 1.9 25,432 Common Shares
Omada Health Inc
Steve Cook Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 13,573 319,759 - - Stock Option (Right to Buy)
Omada Health Inc
Steve Cook Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.28 per share. 26 Jun 2026 13,573 200,782 - 8.3 112,384 Common Stock
Airbnb
Nathan Blecharczyk Director, Chief Strategy Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 146.59 per share. 26 Jun 2026 13,041 86,390 - 146.6 1,911,736 Class A Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 118.66 per share. 26 Jun 2026 12,390 2,451,924 - 118.7 1,470,197 Common Stock
Roivant Sciences Ltd
Keith Manchester Director Sale of securities on an exchange or to another person at price $ 35.28 per share. 26 Jun 2026 12,380 13,689,166 - 35.3 436,766 Common Shares
Roivant Sciences Ltd
Daniel Gold Director Sale of securities on an exchange or to another person at price $ 35.28 per share. 26 Jun 2026 12,380 13,689,166 - 35.3 436,766 Common Shares
Nexstar Media Grp Inc
Perry A. Sook Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 162.26 per share. 26 Jun 2026 12,235 899,044 (1%) 0% 162.3 1,985,309 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 117.09 per share. 26 Jun 2026 12,181 2,486,360 - 117.1 1,426,273 Common Stock
C.H. Robinson Worldwide
David P. Bozeman Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 180.34 per share. 26 Jun 2026 11,693 178,978 (0%) 0% 180.3 2,108,716 Common Stock
Eos Energy Enterprises Inc (Class A)
Michelle Buczkowski Chief Administration Officer Sale of securities on an exchange or to another person at price $ 5.87 per share. 26 Jun 2026 11,469 59,242 - 5.9 67,323 Common Stock
Acadia Pharma Inc
James K. Kihara PRINCIPAL ACCOUNTING OFFICER Sale of securities on an exchange or to another person at price $ 26.08 per share. 26 Jun 2026 11,421 13,088 (0%) 0% 26.1 297,912 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 110.49 per share. 26 Jun 2026 11,277 2,559,147 - 110.5 1,245,996 Common Stock
Septerna Inc
Keith Gottesdiener Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 11,260 11,260 - - Stock Option (Right to Buy)
Wheeler Real Estate Investment Trust Inc
Joseph D. Stilwell Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Jun 2026 11,105 72,383 - - Series B Convertible Preferred Stock
Consumer Portfolio Service Inc
Charles E. Gonel Sr. Vice President Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.00 per share. 26 Jun 2026 11,095 43,752 (0%) 0% 10 110,950 Common Stock, no par value
Adaptive biotech Corp
Sharon Benzeno Chief Commercial Ofc Imm Med Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. 26 Jun 2026 11,034 283,785 (0%) 0% 12.1 133,953 Common Stock
Adaptive biotech Corp
Sharon Benzeno Chief Commercial Ofc Imm Med Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 11,034 1,837 - - Stock Option (right to buy)
Adaptive biotech Corp
Sharon Benzeno Chief Commercial Ofc Imm Med Sale of securities on an exchange or to another person at price $ 21.00 per share. 26 Jun 2026 11,034 272,751 (0%) 0% 21 231,714 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 108.28 per share. 26 Jun 2026 10,848 2,401,310 - 108.3 1,174,621 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 108.28 per share. 26 Jun 2026 10,658 2,402,089 - 108.3 1,154,048 Common Stock
Worthington Steel Inc
Jeffrey R. Klingler Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 10,590 103,802 - 0 Common Shares
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 111.51 per share. 26 Jun 2026 10,366 2,548,781 - 111.5 1,155,913 Common Stock
Paychex
Joseph M. Tucci Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.59 per share. 26 Jun 2026 10,220 77,584 (0%) 0% 60.6 619,230 Common Stock
Paychex
Joseph M. Tucci Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 10,220 0 - - Stock Option
Atlanticus Holdings Corp
William R. McCamey Chief Financial Officer Sale of securities on an exchange or to another person at price $ 109.45 per share. 26 Jun 2026 10,000 137,410 (0%) 0% 109.5 1,094,500 Common Stock
Atlanticus Holdings Corp
Jeffrey A. Howard Director, President & CEO Sale of securities on an exchange or to another person at price $ 109.45 per share. 26 Jun 2026 10,000 673,265 (4%) 0% 109.5 1,094,500 Common Stock
Immunovant Inc
Tiago M. Girao Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.90 per share. 26 Jun 2026 10,000 257,596 (0%) 0% 15.9 159,000 Common Stock
Immunovant Inc
Tiago M. Girao Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 10,000 283,505 - - Stock Option (right to buy)
Immunovant Inc
Tiago M. Girao Chief Financial Officer Sale of securities on an exchange or to another person at price $ 38.46 per share. 26 Jun 2026 10,000 247,596 (0%) 0% 38.5 384,600 Common Stock
Phio Pharma Corp
Robert J. Bitterman Director, Chairman, Pres. & CEO Purchase of securities on an exchange or from another person at price $ 0.99 per share. 26 Jun 2026 10,000 421,421 (22%) 0% 1.0 9,900 Common Stock, $.0001 par value
Eton Pharma Inc
David C. Krempa Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 10,000 96,829 - - Restricted Stock Units
Qualys Inc
Sumedh S. Thakar Director, CEO & PRESIDENT Sale of securities on an exchange or to another person at price $ 120.47 per share. 26 Jun 2026 9,800 236,886 (0%) 0% 120.5 1,180,594 Common Stock
United Therapeutics Corp
Martine A. Rothblatt Director, Chairperson & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. 26 Jun 2026 9,500 50,013 (0%) 0% 135.4 1,286,490 Common Stock
United Therapeutics Corp
Martine A. Rothblatt Director, Chairperson & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 9,500 106,218 - - Stock Option
Cathay General Bancorp
Chang M. Liu Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 9,408 9,408 - - Restricted Stock Units
Ultra Clean Hldgs Inc
Brian E. Harding Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 9,363 37,418 (0%) 0% 0 Common Stock
Airbnb
Nathan Blecharczyk Director, Chief Strategy Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 145.58 per share. 26 Jun 2026 9,202 99,431 - 145.6 1,339,623 Class A Common Stock
Cathay General Bancorp
Dunson K. Cheng Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 9,186 9,186 - - Restricted Stock Units
Vaxcyte Inc
Grant E. Pickering Director, CHIEF EXECUTIVE OFFICER Sale of securities on an exchange or to another person at price $ 55.26 per share. 26 Jun 2026 9,137 458,883 - 55.3 504,956 Common Stock
Privia Health Group Inc
David Mountcastle EVP & Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 8,897 0 - - Stock Option (Right to Purchase)
Cathay General Bancorp
Chang M. Liu Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 8,863 8,863 - - Restricted Stock Units
Eos Energy Enterprises Inc (Class A)
Sumeet Puri Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 5.86 per share. 26 Jun 2026 8,823 173,112 - 5.9 51,703 Common Stock
Airbnb
Nathan Blecharczyk Director, Chief Strategy Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 147.07 per share. 26 Jun 2026 8,790 77,600 - 147.1 1,292,773 Class A Common Stock
Worthington Steel Inc
Timothy A. Adams Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 8,150 52,248 - 0 Common Shares
Neurocrine Biosciences Inc
Darin M. Lippoldt Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 8,110 16,655 - - Non-Qualified Stock Option
Neurocrine Biosciences Inc
Darin M. Lippoldt Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.49 per share. 26 Jun 2026 8,110 62,839 (0%) 0% 81.5 660,884 Common Stock
Neurocrine Biosciences Inc
Darin M. Lippoldt Chief Legal Officer Sale of securities on an exchange or to another person at price $ 170.03 per share. 26 Jun 2026 8,110 54,729 (0%) 0% 170.0 1,378,903 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 109.75 per share. 26 Jun 2026 7,968 2,393,342 - 109.8 874,488 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 109.75 per share. 26 Jun 2026 7,833 2,394,256 - 109.8 859,672 Common Stock
Galectin Therapeutics Inc
Harold H. Shlevin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.23 per share. 26 Jun 2026 7,732 14,232 (0%) 0% 1.2 9,510 Common Stock
Galectin Therapeutics Inc
Harold H. Shlevin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 7,732 52,268 - - Stock Option (right to buy)
Galectin Therapeutics Inc
Harold H. Shlevin Director Sale of securities on an exchange or to another person at price $ 5.00 per share. 26 Jun 2026 7,732 6,500 (0%) 0% 5 38,660 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 110.67 per share. 26 Jun 2026 7,723 2,385,619 - 110.7 854,704 Common Stock
PTC Therapeutics Inc
Neil Almstead CHIEF TECHNICAL OPS OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 7,718 19,687 - - Stock Option (Right to Buy)
PTC Therapeutics Inc
Neil Almstead CHIEF TECHNICAL OPS OFFICER Sale of securities on an exchange or to another person at price $ 85.26 per share. 26 Jun 2026 7,718 60,137 (0%) 0% 85.3 658,037 Common Stock
PTC Therapeutics Inc
Neil Almstead CHIEF TECHNICAL OPS OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.10 per share. 26 Jun 2026 7,718 67,855 (0%) 0% 38.1 294,056 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 110.67 per share. 26 Jun 2026 7,602 2,386,654 - 110.7 841,313 Common Stock
Worthington Steel Inc
John B. Blystone Director, Executive Chairman Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.16 per share. 26 Jun 2026 7,414 233,615 - 35.2 260,676 Common Shares
Redwood Trust Inc
Debora D. Horvath Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 7,259 0 - - Deferred Stock Units
Redwood Trust Inc
Debora D. Horvath Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. 26 Jun 2026 7,259 156,295 (0%) 0% 4.7 34,335 Common stock
Westwood Holdings Grp Inc
Susan M. Byrne Director Emerita Sale of securities on an exchange or to another person at price $ 20.03 per share. 26 Jun 2026 7,192 240,000 (2%) 0% 20.0 144,045 common stock
Westwood Holdings Grp Inc
Susan M. Byrne Director Emerita Sale of securities on an exchange or to another person at price $ 20.03 per share. 26 Jun 2026 7,129 240,108 (2%) 0% 20.0 142,783 common stock
First US Bancshares Inc
Thomas S. Elley SEVP,CFO,Trea,Ast Sec-FUSB Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.11 per share. 26 Jun 2026 7,000 43,000 (0%) 0% 14.1 98,770 Common Stock, $.01 par value
First US Bancshares Inc
Thomas S. Elley SEVP,CFO,Trea,Ast Sec-FUSB Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 7,000 0 - - Stock Option (right to buy)
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 115.69 per share. 26 Jun 2026 6,821 2,498,541 - 115.7 789,121 Common Stock
Immunovant Inc
Jay S. Stout Chief Technology Officer Sale of securities on an exchange or to another person at price $ 38.94 per share. 26 Jun 2026 6,723 211,685 (0%) 0% 38.9 261,794 Common Stock
Vaxcyte Inc
Grant E. Pickering Director, CHIEF EXECUTIVE OFFICER Sale of securities on an exchange or to another person at price $ 54.28 per share. 26 Jun 2026 6,683 468,020 - 54.3 362,720 Common Stock
Blackstone Mortgage Trust Inc (Class A)
Henry N. Nassau Director Grant, award, or other acquisition of securities at price $ 17.43 per share. 26 Jun 2026 6,597 205,479 (0%) 0% 17.4 114,986 Class A Common Stock
Blackstone Mortgage Trust Inc (Class A)
Leonard W. Cotton Director Grant, award, or other acquisition of securities at price $ 17.43 per share. 26 Jun 2026 6,597 96,890 (0%) 0% 17.4 114,986 Class A Common Stock
Blackstone Mortgage Trust Inc (Class A)
Lynne B. Sagalyn Director Grant, award, or other acquisition of securities at price $ 17.43 per share. 26 Jun 2026 6,597 162,700 (0%) 0% 17.4 114,986 Class A Common Stock
Blackstone Mortgage Trust Inc (Class A)
Michael B. Nash Director Grant, award, or other acquisition of securities at price $ 17.43 per share. 26 Jun 2026 6,597 558,272 (0%) 0% 17.4 114,986 Class A Common Stock
Blackstone Mortgage Trust Inc (Class A)
Nnenna J. Lynch Director Grant, award, or other acquisition of securities at price $ 17.43 per share. 26 Jun 2026 6,597 41,805 (0%) 0% 17.4 114,986 Class A Common Stock
Blackstone Mortgage Trust Inc (Class A)
Gilda Perez-Alvarado Director Grant, award, or other acquisition of securities at price $ 17.43 per share. 26 Jun 2026 6,597 26,504 (0%) 0% 17.4 114,986 Class A Common Stock
Blackstone Mortgage Trust Inc (Class A)
Chen Yi Hsu Director Grant, award, or other acquisition of securities at price $ 17.43 per share. 26 Jun 2026 6,597 10,850 (0%) 0% 17.4 114,986 Class A Common Stock
Vaxcyte Inc
Grant E. Pickering Director, CHIEF EXECUTIVE OFFICER Sale of securities on an exchange or to another person at price $ 56.12 per share. 26 Jun 2026 6,417 452,466 - 56.1 360,128 Common Stock
La-Z-Boy Inc
Melinda D. Whittington Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.95 per share. 26 Jun 2026 6,376 397,365 (0%) 0% 40.9 261,097 Common Shares
Paychex
Joseph M. Tucci Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.10 per share. 26 Jun 2026 6,313 71,271 (0%) 0% 98.1 619,305 Common Stock
Amarin Corp (ADR)
Aaron D. Berg President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 6,250 6,250 - - Restricted Stock Unit
Amarin Corp (ADR)
Aaron D. Berg President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 6,250 88,845 (0%) 0% - American Depositary Shares
First US Bancshares Inc
Thomas S. Elley SEVP,CFO,Trea,Ast Sec-FUSB Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.75 per share. 26 Jun 2026 6,220 36,780 (0%) 0% 16.8 104,185 Common Stock, $.01 par value
Worthington Steel Inc
Clifford Larivey President Flat Rolled Stl Proc Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 6,110 70,418 - 0 Common Shares
vTv Therapeutics Inc (Class A)
Daniel K. Spiegelman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 6,000 16,000 - - Director stock option (right to buy)
vTv Therapeutics Inc (Class A)
Anne M. Phillips Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 6,000 16,860 - - Director stock option (right to buy)
vTv Therapeutics Inc (Class A)
Fahed Al Marzooqi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 6,000 19,555 - - Director stock option (right to buy)
Privia Health Group Inc
David Mountcastle EVP & Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 5,962 0 - - Stock Option (Right to Purchase)
SEI Investments Co.
Alfred P. West Chairman Emeritus Sale of securities on an exchange or to another person at price $ 87.18 per share. 26 Jun 2026 5,652 6,820,131 (4%) 0% 87.2 492,741 Common Stock
Cathay General Bancorp
Albert Jen-Wen Wang EVP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 5,640 5,640 - - Restricted Stock Units
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 105.78 per share. 26 Jun 2026 5,549 2,446,375 - 105.8 586,973 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 105.78 per share. 26 Jun 2026 5,471 2,446,453 - 105.8 578,722 Common Stock
Agenus Inc
Garo H. Armen Director, See Remarks Grant, award, or other acquisition of securities at price $ 3.03 per share. 26 Jun 2026 5,364 366,256 (0%) 0% 3.0 16,253 Common Stock
Asana Inc (Class A)
Katie Colendich GC, Corporate Secretary Sale of securities on an exchange or to another person at price $ 6.69 per share. 26 Jun 2026 5,242 176,598 - 6.7 35,043 Class A Common Stock
Micron Tech
Sanjay Mehrotra Director, President and CEO Sale of securities on an exchange or to another person at price $ 1132.37 per share. 26 Jun 2026 5,123 378,902 (0%) 0% 1132.4 5,801,132 Common Stock
Beta Bionics Inc
Stephen Feider Chief Financial Officer Sale of securities on an exchange or to another person at price $ 17.05 per share. 26 Jun 2026 5,104 165,931 - 17.0 87,006 Common Stock
Beta Bionics Inc
Stephen Feider Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. 26 Jun 2026 5,104 171,157 - 5.1 26,030 Common Stock
Beta Bionics Inc
Stephen Feider Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 5,104 44,591 - - Employee Stock Option (right to buy)
Beta Bionics Inc
Stephen Feider Chief Financial Officer Sale of securities on an exchange or to another person at price $ 17.05 per share. 26 Jun 2026 5,104 166,053 - 17.0 87,006 Common Stock
Liberty Latin America Ltd (Class A)
John M. Winter SVP, CLO AND SECRETARY Purchase of securities on an exchange or from another person at price $ 19.67 per share. 26 Jun 2026 5,071 64,547 - 19.7 99,738 Series A Preference Shares
Silvergate Cap Corp (Class A)
Paul R. Buckman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 5,046 63,750 - 0 Common Stock
Silvergate Cap Corp (Class A)
Kevin K. Sidow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 5,046 25,056 - 0 Common Stock
Silvergate Cap Corp (Class A)
Casey M. Tansey Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 5,046 52,712 - 0 Common Stock
Silvergate Cap Corp (Class A)
Richard J. Buchholz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 5,046 18,712 - 0 Common Stock
Silvergate Cap Corp (Class A)
Andrew Hykes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 5,046 6,769 - 0 Common Stock
Vericel Corp
Jonathan Mark Hopper Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 5,000 20,000 - - Stock Option (Right to Buy)
Vericel Corp
Jonathan Mark Hopper Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.82 per share. 26 Jun 2026 5,000 80,753 (0%) 0% 29.8 149,100 Common Stock
Vericel Corp
Jonathan Mark Hopper Chief Medical Officer Sale of securities on an exchange or to another person at price $ 45.00 per share. 26 Jun 2026 5,000 75,753 (0%) 0% 45 225,000 Common Stock
Vericel Corp
Jonathan Mark Hopper Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.82 per share. 26 Jun 2026 5,000 80,753 (0%) 0% 29.8 149,100 Common Stock
Vericel Corp
Jonathan Mark Hopper Chief Medical Officer Sale of securities on an exchange or to another person at price $ 45.00 per share. 26 Jun 2026 5,000 75,753 (0%) 0% 45 225,000 Common Stock
Vericel Corp
Jonathan Mark Hopper Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 5,000 25,000 - - Stock Option (Right to Buy)
Vericel Corp
Joseph A. Mara Chief Financial Officer Sale of securities on an exchange or to another person at price $ 44.75 per share. 26 Jun 2026 5,000 16,009 (0%) 0% 44.8 223,750 Common Stock
AIAI Holdings Corp Ordinary
Barbara Barton Weiszhaar SVP/CAO Sale of securities on an exchange or to another person at price $ 15.21 per share. 26 Jun 2026 5,000 176,120 - 15.2 76,050 Class A Common Stock
AIAI Holdings Corp Ordinary
Stephanie Liebman EVP/CFO Sale of securities on an exchange or to another person at price $ 14.75 per share. 26 Jun 2026 5,000 176,039 - 14.8 73,750 Class A Common Stock
AIAI Holdings Corp Ordinary
Stephanie Liebman EVP/CFO Sale of securities on an exchange or to another person at price $ 15.21 per share. 26 Jun 2026 5,000 181,039 - 15.2 76,050 Class A Common Stock
Beta Bionics Inc
Stephen Feider Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. 26 Jun 2026 4,982 171,035 - 5.1 25,408 Common Stock
Beta Bionics Inc
Stephen Feider Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 4,982 44,713 - - Employee Stock Option (right to buy)
Beta Bionics Inc
Stephen Feider Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 4,896 39,817 - - Employee Stock Option (right to buy)
Beta Bionics Inc
Stephen Feider Chief Financial Officer Sale of securities on an exchange or to another person at price $ 17.03 per share. 26 Jun 2026 4,896 165,931 - 17.0 83,381 Common Stock
Beta Bionics Inc
Stephen Feider Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. 26 Jun 2026 4,896 170,827 - 5.1 24,970 Common Stock
Beta Bionics Inc
Stephen Feider Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 4,896 39,695 - - Employee Stock Option (right to buy)
Beta Bionics Inc
Stephen Feider Chief Financial Officer Sale of securities on an exchange or to another person at price $ 17.03 per share. 26 Jun 2026 4,896 166,053 - 17.0 83,381 Common Stock
Beta Bionics Inc
Stephen Feider Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. 26 Jun 2026 4,896 170,949 - 5.1 24,970 Common Stock
Worthington Steel Inc
Joseph Y Heuer General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 4,890 19,169 - 0 Common Shares
Cathay General Bancorp
Dunson K. Cheng Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 4,875 4,875 - - Restricted Stock Units
Genesco Inc
Mimi Eckel Vaughn Director, Board Chair, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.18 per share. 26 Jun 2026 4,847 445,481 (3%) 0% 36.2 175,364 Common Stock
Modiv Inc (Class C)
Aaron Scott Halfacre Director, CEO and President Purchase of securities on an exchange or from another person at price $ 17.50 per share. 26 Jun 2026 4,766 133,244 - 17.5 83,409 COMMON STOCK, CLASS C
Cathay General Bancorp
Dunson K. Cheng Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 4,593 4,593 - - Restricted Stock Units
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 109.79 per share. 26 Jun 2026 4,562 488,796 - 109.8 500,862 Common Stock
J.M. Smucker
Jeannette L. Knudsen Chief Legal Officer Sale of securities on an exchange or to another person at price $ 115.08 per share. 26 Jun 2026 4,353 16,835 (0%) 0% 115.1 500,943 Common Shares
VF Corp
Richard T. Carucci Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 4,317 100,113 - - Phantom Stock-d
Westwood Holdings Grp Inc
Susan M. Byrne Director Emerita Sale of securities on an exchange or to another person at price $ 19.39 per share. 26 Jun 2026 4,274 247,237 (2%) 0% 19.4 82,856 common stock
Westwood Holdings Grp Inc
Susan M. Byrne Director Emerita Sale of securities on an exchange or to another person at price $ 19.39 per share. 26 Jun 2026 4,274 247,192 (2%) 0% 19.4 82,856 common stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 107.57 per share. 26 Jun 2026 3,958 525,760 - 107.6 425,762 Common Stock
Paychex
Joseph M. Tucci Director Sale of securities on an exchange or to another person at price $ 98.25 per share. 26 Jun 2026 3,907 67,364 (0%) 0% 98.3 383,863 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 114.94 per share. 26 Jun 2026 3,896 479,718 - 114.9 447,806 Common Stock
SEI Investments Co.
Alfred P. West Chairman Emeritus Sale of securities on an exchange or to another person at price $ 87.67 per share. 26 Jun 2026 3,838 6,825,783 (4%) 0% 87.7 336,477 Common Stock
Terex Corp
David A. Sachs Director Grant, award, or other acquisition of securities at price $ 71.81 per share. 26 Jun 2026 3,760 279,590 (0%) 0% 71.8 270,006 Common Stock, par value $.01
Terex Corp
Srikanth Padmanabhan Director Grant, award, or other acquisition of securities at price $ 71.81 per share. 26 Jun 2026 3,760 6,641 (0%) 0% 71.8 270,006 Common Stock, $ .01 par value
Terex Corp
Sandra E. O’Connor Director Grant, award, or other acquisition of securities at price $ 71.81 per share. 26 Jun 2026 3,760 47,264 (0%) 0% 71.8 270,006 Common Stock, $.01 par value
Terex Corp
Oluseun Salami Director Grant, award, or other acquisition of securities at price $ 71.81 per share. 26 Jun 2026 3,760 16,740 (0%) 0% 71.8 270,006 Common Stock, $ .01 par value
Terex Corp
Kathleen M. Steele Director Grant, award, or other acquisition of securities at price $ 71.81 per share. 26 Jun 2026 3,760 16,287 (0%) 0% 71.8 270,006 Common Stock, $ .01 par value
CarMax
David W. McCreight Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,696 39,530 (0%) 0% 0 Common Stock
CarMax
Sona Chawla Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,696 25,398 (0%) 0% 0 Common Stock
CarMax
Peter J. Bensen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,696 28,492 (0%) 0% 0 Common Stock
CarMax
Thomas J. Folliard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,696 227,754 (0%) 0% 0 Common Stock
CarMax
William C. Cobb Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,696 3,696 (0%) 0% 0 Common Stock
CarMax
Mark F. O'Neil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,696 33,186 (0%) 0% 0 Common Stock
CarMax
Pietro Satriano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,696 20,011 (0%) 0% 0 Common Stock
CarMax
Marcella Shinder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,696 28,689 (0%) 0% 0 Common Stock
CarMax
James Francis Kessler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,696 3,696 (0%) 0% 0 Common Stock
Orchid Island Cap Inc
Robert E. Cauley Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 3,694 126,995 - - Performance Units
Orchid Island Cap Inc
Robert E. Cauley Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 3,694 226,984 (0%) 0% 0 Common Stock
Orasure Tech Inc
Steven Kyle Boyd Director Grant, award, or other acquisition of securities at price $ 4.43 per share. 26 Jun 2026 3,666 163,234 (0%) 0% 4.4 16,250 Common Stock
Micron Tech
Sanjay Mehrotra Director, President and CEO Sale of securities on an exchange or to another person at price $ 1141.46 per share. 26 Jun 2026 3,645 373,710 (0%) 0% 1141.5 4,160,622 Common Stock
Signet Jewelers Ltd
Helen E. McCluskey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,632 39,381 (0%) 0% 0 Common Shares, par value $0.18
Cathay General Bancorp
Diana G. Deen EVP, Chief Risk Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,400 3,400 - - Restricted Stock Units
La-Z-Boy Inc
Melinda D. Whittington Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.95 per share. 26 Jun 2026 3,381 393,984 (0%) 0% 41.0 138,452 Common Shares
CarGurus Inc (Class A)
Javier Esquivel Zamora General Counsel and Secretary Sale of securities on an exchange or to another person at price $ 32.61 per share. 26 Jun 2026 3,367 99,694 (0%) 0% 32.6 109,798 Class A Common Stock
Credit Acceptance Corp
Erin J. Kerber Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 3,303 5,500 - - Employee Stock Option (right to buy)
Credit Acceptance Corp
Erin J. Kerber Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 454.11 per share. 26 Jun 2026 3,303 31,430 (0%) 0% 454.1 1,499,925 Common Stock
Liquidity Services Inc
John P. Daunt EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 3,287 15,413 - - Stock Option Grant
Liquidity Services Inc
John P. Daunt EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.62 per share. 26 Jun 2026 3,287 41,373 (0%) 0% 21.6 71,065 Common Stock
Park-Ohio Holdings Corp
Robert D. Vilsack Secretary & CLO Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.06 per share. 26 Jun 2026 3,266 192,943 (1%) 0% 39.1 127,570 Common Stock
Canopy Growth Corp
Joe Bayern Director Sale of securities on an exchange or to another person at price $ 0.92 per share. 26 Jun 2026 3,197 145,127 (0%) 0% 0.9 2,953 Common Shares
Canopy Growth Corp
Margaret Shan Atkins Director Sale of securities on an exchange or to another person at price $ 0.92 per share. 26 Jun 2026 3,197 146,517 (0%) 0% 0.9 2,953 Common Shares
Amarin Corp (ADR)
Aaron D. Berg President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.35 per share. 26 Jun 2026 3,197 85,648 (0%) 0% 16.4 52,271 American Depositary Shares
Cathay General Bancorp
Albert Jen-Wen Wang EVP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,134 3,134 - - Restricted Stock Units
Cathay General Bancorp
Albert Sun EVP, Chief Credit Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 3,102 3,102 - - Restricted Stock Units
Park-Ohio Holdings Corp
Robert D. Vilsack Secretary & CLO Sale of securities on an exchange or to another person at price $ 38.40 per share. 26 Jun 2026 3,100 188,471 (1%) 0% 38.4 119,040 Common Stock
Ionis Pharma Inc
Patrick R. O'Neil EVP CLO & General Counsel Sale of securities on an exchange or to another person at price $ 80.00 per share. 26 Jun 2026 3,069 61,470 (0%) 0% 80 245,520 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 117.85 per share. 26 Jun 2026 3,069 473,996 - 117.9 361,682 Common Stock
Orchid Island Cap Inc
George H. Haas Director, Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 3,031 97,939 - - Performance Units
Orchid Island Cap Inc
George H. Haas Director, Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jun 2026 3,031 138,715 (0%) 0% 0 Common Stock
Kymera Therapeutics Inc
Bruce Booth Director Sale of securities on an exchange or to another person at price $ 107.76 per share. 26 Jun 2026 3,024 466,077 - 107.8 325,866 Common Stock
MediaAlpha Inc (Class A)
Amy Yeh Chief Technology Officer Sale of securities on an exchange or to another person at price $ 11.16 per share. 26 Jun 2026 3,000 566,985 - 11.2 33,480 Class A Common Stock
Immunovant Inc
Melanie Gloria Chief Operating Officer Sale of securities on an exchange or to another person at price $ 38.95 per share. 26 Jun 2026 2,966 224,393 (0%) 0% 39.0 115,526 Common Stock
Scynexis Inc
David C. Hastings Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 2,875 2,875 - - Stock Option (Right to Buy)
Scynexis Inc
David C. Hastings Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 2,875 11,522 (0%) 0% 0 Common Stock
Scynexis Inc
Guy Macdonald Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 2,875 2,875 - - Stock Option (Right to Buy)
Scynexis Inc
Guy Macdonald Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 2,875 12,625 (0%) 0% 0 Common Stock
Scynexis Inc
Armando Anido Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 2,875 11,750 (0%) 0% 0 Common Stock
Scynexis Inc
Armando Anido Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 2,875 2,875 - - Stock Option (Right to Buy)
Scynexis Inc
Ann F. Hanham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 2,875 11,577 (0%) 0% 0 Common Stock
Scynexis Inc
Ann F. Hanham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 2,875 2,875 - - Stock Option (Right to Buy)
Scynexis Inc
Brian Philippe Tinmouth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 2,875 2,875 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.